Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Dec. 31, 2015 | Mar. 22, 2016 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Dec. 31, 2015 | |
Trading Symbol | lexg | |
Entity Registrant Name | Lithium Exploration Group, Inc. | |
Entity Central Index Key | 1,375,576 | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 11,669,869 | |
Entity Current Reporting Status | Yes | |
Entity Voluntary Filers | No | |
Entity Well Known Seasoned Issuer | No | |
Document Fiscal Year Focus | 2,016 | |
Document Fiscal Period Focus | Q2 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Dec. 31, 2015 | Jun. 30, 2015 |
Current | ||
Cash and cash equivalents | $ 13,796 | $ 64,098 |
Receivable | 0 | 13,421 |
Loan receivable | 0 | 20,000 |
Prepaid expenses | 2,788 | 2,788 |
Current assets held for sale | 23,136 | 14,713 |
Total current assets | 39,720 | 115,020 |
Total Assets | 39,720 | 115,020 |
Current | ||
Accounts payable and accrued liabilities | 196,773 | 65,962 |
Derivative liability - convertible promissory notes | 1,015,698 | 1,646,448 |
Derivative liability - warrants | 749,582 | 143,375 |
Due to related party | 115,000 | 115,000 |
Convertible promissory notes - net of unamortized discount | 741,042 | 533,994 |
Accrued interest - convertible promissory notes | 106,143 | 60,022 |
Current liabilities held for sale | 6,034 | 6,696 |
Total Current Liabilities | 2,930,272 | 2,571,497 |
DEFICIT Lithium Explorations Group, Inc. Stockholders' Deficit | ||
Capital stock Authorized: 100,000,000 preferred shares, $0.001 par value Issued and outstanding: Nil preferred shares (June 30, 2015 - Nil) | 0 | 0 |
Capital stock 10,000,000,000 (June 30, 2015 - 2,000,000,000) common shares, $0.001 par value Issued and outstanding: 11,669,869 common shares (June 30, 2015 - 7,574,353) | 11,662 | 7,575 |
Additional paid-in capital | 47,816,707 | 47,383,231 |
Accumulated other comprehensive loss | (37,708) | (29,486) |
Accumulated deficit | (50,329,264) | (49,504,347) |
Total Lithium Exploration Group, Inc. Stockholders' Deficit | (2,538,603) | (2,143,027) |
Non-controlling interest | (351,949) | (313,450) |
Total Deficit | (2,890,552) | (2,456,477) |
Total Liabilities and Stockholders' Deficit | $ 39,720 | $ 115,020 |
Condensed Consolidated Balance3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2015 | Jun. 30, 2015 |
Preferred Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Preferred Stock, Par Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Shares Authorized | 10,000,000,000 | 2,000,000,000 |
Common Stock, Par Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Issued | 11,669,869 | 7,574,353 |
Common Stock, Shares, Outstanding | 11,669,869 | 7,574,353 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |
Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
Operating Expenses: | ||||
Mining | 0 | 0 | 5,000 | 15,000 |
Selling, general and administrative | 167,606 | 247,737 | 309,415 | 585,728 |
Total operating expenses | 167,606 | 247,737 | 314,415 | 600,728 |
(Loss) from operations | (167,606) | (247,737) | (314,415) | (600,728) |
Other income (expenses) | ||||
Interest expense | (255,178) | (311,832) | (601,960) | (1,035,903) |
Gain (loss) on change in the fair value of derivative liability | 8,906,059 | (305,132) | 464,286 | 2,918,297 |
Amortization of debt discount | (149,379) | (875,252) | (320,322) | (1,584,896) |
Bad-debt write off | 0 | 0 | (20,000) | 0 |
Gain (loss) on disposal of business operations | (72) | 0 | 7,565 | 0 |
Equity in income (loss) of unconsolidated affiliate | 0 | (42,278) | 0 | 6,145 |
Income (loss) before income taxes | 8,333,824 | (1,782,231) | (784,846) | (297,085) |
Provision for Income Taxes | 0 | 0 | 0 | 0 |
Net loss for the period | 8,333,824 | (1,782,231) | (784,846) | (297,085) |
(Loss) from discontinued operations | (24,496) | (133,316) | (78,570) | (281,887) |
Net Income (loss) | 8,309,328 | (1,915,547) | (863,416) | (578,972) |
Less: Net loss attributable to the non-controlling interest | (12,003) | (65,325) | (38,499) | (138,125) |
Net income (loss) attributable to Lithium Exploration Group, Inc. Common shareholders | $ 8,321,331 | $ (1,850,222) | $ (824,917) | $ (440,847) |
Basic and Diluted Income (loss) per Common Share | $ 0.72 | $ (8.80) | $ (0.08) | $ (3.22) |
Basic and Diluted Weighted Average Number of Common Shares Outstanding | 11,500,561 | 210,194 | 10,158,023 | 136,777 |
Comprehensive loss: | ||||
Net Income (loss) | $ 8,309,328 | $ (1,915,547) | $ (863,416) | $ (578,972) |
Foreign currency translation adjustment | 1,336 | (5,970) | (8,222) | (7,834) |
Comprehensive income (loss) | 8,310,694 | (1,921,517) | (871,638) | (586,806) |
Comprehensive (loss) attributable to non-controlling interest | (12,003) | (65,325) | (38,499) | (138,125) |
Comprehensive income (loss) attributable to Lithium Exploration Group, Inc. | $ 8,322,697 | $ (1,856,192) | $ (833,139) | $ (448,681) |
Condensed Consolidated Stateme5
Condensed Consolidated Statements of Changes in Stockholders Deficit - 6 months ended Dec. 31, 2015 - USD ($) | Preferred Shares [Member] | Common Shares [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Deficit [Member] | Non-controlling interest [Member] | Total |
Beginning Balance at Jun. 30, 2015 | $ 0 | $ 7,575 | $ 47,383,231 | $ (29,486) | $ (49,504,347) | $ (313,450) | $ (2,456,477) |
Beginning Balance (Shares) at Jun. 30, 2015 | 7,574,353 | ||||||
Common shares issued for debt conversion | $ 4,086 | 111,958 | 116,044 | ||||
Common shares issued for debt conversion (Shares) | 4,087,472 | ||||||
Common shares issued for the reclassification of derivative liability on convertible notes | 261,331 | 261,331 | |||||
Common shares issued for fractional shares adjustment | $ 1 | ||||||
Common shares issued for fractional shares adjustment (Shares) | 8,044 | ||||||
Disposal of business operations | 60,187 | 60,187 | |||||
Foreign exchange translation | (8,222) | (8,222) | |||||
Net loss for the period | (824,917) | (38,499) | (863,416) | ||||
Ending Balance at Dec. 31, 2015 | $ 0 | $ 11,662 | $ 47,816,707 | $ (37,708) | $ (50,329,264) | $ (351,949) | $ (2,890,552) |
Ending Balance (Shares) at Dec. 31, 2015 | 11,669,869 |
Condensed Consolidated Stateme6
Condensed Consolidated Statements of Cash Flows - USD ($) | 6 Months Ended | |
Dec. 31, 2015 | Dec. 31, 2014 | |
Cash Flows from Operating Activities | ||
Net loss from continuing operations | $ (784,846) | $ (297,085) |
Loss from discontinued operations | (78,570) | (281,887) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Equity in income of investment held for sale | $ 0 | (6,145) |
Common shares issued for consulting fees | 118,990 | |
Non-cash Interest expense | $ 545,852 | 908,387 |
Investment impairment | 60,178 | 0 |
Bad debt written-off | $ 20,000 | 0 |
Common shares issued for interest expenses | 99,567 | |
Gain on change in the fair value of derivative liability | $ (464,286) | (2,918,297) |
Amortization of discount | 320,322 | 1,584,896 |
Changes in operating assets and liabilities: | ||
Receivable, net | 13,421 | 0 |
Prepaid expenses | 0 | 16,610 |
Accrued interest | 46,121 | 27,947 |
Accounts payable and accrued liabilities | 130,812 | 33,686 |
Net cash used in operating activities from continuing operations | (190,996) | (713,331) |
Net cash used in operating activities from discontinued operations | (9,084) | 15,779 |
Net cash used in operating activities | (200,080) | (697,552) |
Cash Flows from Financing Activities | ||
Repayment to related party | 0 | (45,332) |
Proceed from issuance of convertible promissory notes | 158,000 | 750,000 |
Net cash provided by financing activities | 158,000 | 704,668 |
Effect of foreign exchange | (8,222) | (7,834) |
Decrease in cash and cash equivalents | (50,302) | (718) |
Cash and cash equivalents - beginning of period | 64,098 | 57,632 |
Cash and cash equivalents - end of period | 13,796 | 56,914 |
Cash paid during the period for: | ||
Interest | 0 | 0 |
Income taxes | 0 | 0 |
Non-cash investing and financing activities: | ||
Common stock issued for debt conversion | 116,043 | 1,474,202 |
Common stock issued on cashless exercise of warrants | 0 | 2,371,934 |
Derivative liability re-classed to additional paid in capital | 261,331 | 2,286,445 |
Debt discount on convertible note and warrants | 155,231 | 743,481 |
Initial derivative liability on note issuance | $ 701,073 | $ 1,642,368 |
Organization
Organization | 6 Months Ended |
Dec. 31, 2015 | |
Organization [Text Block] | 1. Organization Lithium Exploration Group, Inc. (formerly Mariposa Resources, Ltd.) (the “Company”) was incorporated on May 31, 2006 in the State of Nevada, U.S.A. It is based in Phoenix, Arizona, USA. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is June 30. Effective November 30, 2010, the Company changed its name to “Lithium Exploration Group, Inc.,” by way of a merger with its wholly-owned subsidiary Lithium Exploration Group, Inc., which was formed solely for the change of name. A wholly owned subsidiary, 1617437 Alberta Ltd. was incorporated in the province of Alberta, Canada on July 8, 2011. Effective October 2, 2013, the subsidiary changed its name to Alta Disposal Ltd. On October 18, 2013, the Company acquired 51% interest in Alta Disposal Morinville Ltd. (formerly Blue Tap Resources Ltd.). Effective September 4, 2015, the Company entered into an Asset Purchase Agreement with Cancen Oil Canada whereby the Company agrees to sell all right, title and interest of Alta Disposal Morinville Ltd. assets for total purchase price of CAD$10,000 approximately USD$7,466. On March 1, 2014, the Company through its 100% subsidiary Alta Disposal Ltd. acquired 50% interest in Tero Oilfield Services Ltd. (the “Tero”) On May 1, 2015, the Company entered into a Share Purchase Agreement with an individual and disposed its 50% interest in Tero. The Company is engaged principally in the acquisition, exploration, and development of resource properties. Prior to June 25, 2009, the Company had the right to conduct exploration work on 20 mineral mining claims in Esmeralda County, Nevada, U.S.A. On July 31, 2009, the Company acquired an option to enter into a joint venture for the management and ownership of the Jack Creek Project, a mining project located in Elko County, Nevada. On September 25, 2009, the joint venture was terminated and the Company entered into an agreement with Beeston Enterprises Ltd., under which the Company was granted an option to acquire an undivided 50% interest in eight mineral claims located in the Clinton Mining District of British Columbia, Canada. On December 16, 2010, the Company entered into an Assignment Agreement to acquire an undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada (see Note 5). On November 8, 2011, the Company entered into a letter agreement with Glottech-USA. Pursuant to the terms of the agreement, the Company was granted an exclusive license to use and distribute the technology within the Swan Hills region of Alberta as well as a non-exclusive right to distribute the technology within Canada. |
Significant Accounting Policies
Significant Accounting Policies | 6 Months Ended |
Dec. 31, 2015 | |
Significant Accounting Policies [Text Block] | 2. Significant Accounting Policies Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the six months ended December 31, 2015 and 2014 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the six months ended December 31, 2015 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to Dec 31, 2015 and 2014 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed balance sheet as of June 30, 2015 was restated during the period ending December 31, 2015 and has been carried forward for the period ending December 31, 2015, and do not include all disclosures required by the accounting principles generally accepted in the United States of America. Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework. Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments. Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $13,796 and $64,098 in cash and cash equivalents at December 31, 2015 and June 30, 2015, respectively. Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of December 31, 2015 and June 30, 2015, the Company had $Nil and $Nil, respectively, in deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period. Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,” Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive. Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending December 31, 2015 closing rate at 0.7225 CDN$: US$, average rate at 0.7565 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$. Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,” Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure. Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the condensed consolidated statements of operations and comprehensive Income (Loss). Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date. Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured. Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts. Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. |
Capital Stock
Capital Stock | 6 Months Ended |
Dec. 31, 2015 | |
Capital Stock [Text Block] | 3. Capital Stock On January 19, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 20 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective February 25, 2015. On July 13, 2015, the Company's board of directors consented to effect a reverse stock split of the Company’s issued and outstanding shares of common stock on a basis of 200 old shares of common stock for one 1 new share of common stock. The reverse stock split was reviewed and approved for filing by the FNRA effective December 31, 2015. Upon effect of the reverse stock split the issued and outstanding shares pre-split as at December 31, 2015 were 2,333,973,894 and the post-split were 11,669,869. The Company’s authorized capital will not be affected by the reverse stock split. The split is reflected retrospectively in the accompanying financial statements. Authorized Stock At inception, the Company authorized 100,000,000 common shares and 100,000,000 preferred shares, both with a par value of $0.001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. On April 8, 2009, the Company increased the number of authorized shares to 600,000,000 shares, of which 500,000,000 shares are designated as common stock par value $0.001 per share, and 100,000,000 shares are designated as preferred stock, par value $0.001 per share. On October 25, 2012, the Company designated 20,000,000 series A convertible preferred stock with a par value of $0.001 per share and stated value of $100 per share. The designated preferred stock is convertible at the option of the holder, at any time beginning one year from the date such shares are issued, into common stock of the Company with a par value of $0.001. All shares of common stock of the Company, shall be of junior rank to all series A preferred stock in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. All other shares of preferred stock shall be of junior rank to all series A preferred shares in respect to the preferences as to distributions and payments upon the liquidation, dissolution and winding up of the Company. On January 3, 2014, the Company designated 2,000,000 series B convertible preferred stock with a par value $0.001 per share, issuable only in consideration of the extinguishment of existing debt convertible in to the Company’s common stock with a par value of $0.001. The designated preferred stock shall be issued on the basis of 1 preferred stock for each $1 of convertible debt. The series B convertible preferred stock shall be subordinate to and rank junior to all indebtedness of the Company now or hereafter outstanding. On October 17, 2014, the Company amended its Articles of Incorporation, which amendment was filed with the Nevada Secretary of State on October 17, 2014, to increase the authorized capital of its common shares from 500,000,000 common shares, par value $0.001 to 2,000,000,000 common shares, par value $0.001. The Company's authorized capital consists of 2,000,000,000 common shares and 100,000,000 preferred shares, all with a par value of $0.001. Effective June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of preferred stock as series A preferred stock. The series A preferred stock, par value $0.001, will rank senior to the Company’s common stock, carrying general voting rights with the common stock at the rate of 62 votes per share. The series A preferred stock will be deemed cancelled within 1 year of issuance and are not entitled to share in dividends or other distributions. So long as any shares of series A preferred stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of series A preferred stock will be required for any change to the Company’s Articles of Incorporation. Effective September 9, 2015, the Company increase the authorized capital of its common shares from 2,000,000,000 common shares, par value $0.001 to 10,000,000,000 common shares, par value $0.001. Share Issuances Common Stock Issuance For the period ended December 31, 2015: On July 8, 2015, the Company issued 125,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 10, 2015, the Company issued 201,465 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 21, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On July 22, 2015, the Company issued 100,000 common shares at a deemed price of $0.05 per share for promissory note conversion (Note 6). On July 29, 2015, the Company issued 298,269 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On August 17, 2015, the Company issued 250,000 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 80,801 common shares at a deemed price of $0.04 per share for promissory note conversion (Note 6). On September 11, 2015, the Company issued 434,084 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 15, 2015, the Company issued 438,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 486,623 common shares at a deemed price of $0.02 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 475,000 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On September 18, 2015, the Company issued 394,231 common shares at a deemed price of $0.03 per share for promissory note conversion (Note 6). On October 8, 2015, the Company issued 8,044 common shares at a deemed price of $0.0001 per share to the depository trust as a result of the reverse stock split round-up. On October 28, 2015 the Company issued 554,000 common shares at a deemed price of $0.01 per share for promissory note conversion (Note 6). Issuances of Preferred Shares On June 22, 2015, the Company designated 50,000,000 of its 100,000,000 authorized shares of Preferred Stock as Series “A” Preferred Stock. The Series “A’ Preferred Stock, par value $0.001, ranks senior to the common stock and carries general voting rights with the common stock at the rate of 62 votes per share. The Series “A” Preferred Stock will be deemed cancelled within 1 year of issuance and is not entitled to share in dividends or other distributions. So long as any shares of Series “A” Preferred Stock are outstanding, the affirmative vote of not less than 75% of those outstanding shares of Series “A” Preferred Stock will be required for any change to articles of incorporation. On July 6, 2015, the Company issued 130,000 Series “A” preferred shares in consideration of the release and discharge of a first ranking general security interest over all current and future assets of Alta Disposal Ltd. that was granted to secure to the promissory note entered into on July 22, 2014. These shares were issued at par value of $0.001. These shares were subsequently cancelled on December 5, 2015 therefore the net impact on share capital is nil. |
Provision For Income Taxes
Provision For Income Taxes | 6 Months Ended |
Dec. 31, 2015 | |
Provision For Income Taxes [Text Block] | 4. Provision for Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. Exploration stage deferred tax assets arising as a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty of their utilization in future periods. Operating loss carryforwards generated during the period from May 31, 2006 (date of inception) through December 31, 2015 of approximately $13,213,863 will begin to expire in 2026. Accordingly, deferred tax assets were offset by the valuation allowance that increased by approximately $390,542 and $1,130,089 during the periods ended December 31, 2015 and June 30, 2015 respectively. The Company follows the provisions of uncertain tax positions as addressed in FASC 740-10-65-1. The Company recognized approximately no increase in the liability for unrecognized tax benefits. The Company has no tax position at December 31, 2015 for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. No such interest or penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at December 31, 2015. The Company’s utilization of any net operating loss carry forward may be unlikely as a result of its intended exploration stage activities. The tax years for June 30, 2015, June 30, 2014, June 30, 2013 and June 30, 2012 are still open for examination by the Internal Revenue Service (IRS). For the six months ended December 31, 2015 Amount Tax Effect (35% Net loss $ 784,846 $ 274,696 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest Expense (545,832 ) (191,041 ) Gain on derivative liability 464,286 162,500 Amortization of discount (320,322 ) (112,113 ) Impairment (7,565 ) (2,648 ) Total 390,542 136,690 Valuation allowance (390,542 ) (136,690 ) Net deferred tax asset (liability) $ - $ - For the six months ended December 31, 2014 Amount Tax Effect ( 35%) Net loss $ 297,085 $ 103,980 Shares issued for consulting fees, mining expenses, investor relation and director fees (118,990 ) (41,647 ) Shares issued for interest expenses (99,567 ) (34,849 ) Amortization of discount (1,584,896 ) (554,714 ) Interest Expense (898,887 ) (314,610 ) Gain on derivative liability 2,918,297 1,021,404 Total 513,042 179,565 Valuation allowance (513,042 ) (179,565 ) Net deferred tax asset (liability) $ - $ - |
Mineral Property Costs
Mineral Property Costs | 6 Months Ended |
Dec. 31, 2015 | |
Mineral Property Costs [Text Block] | 5. Mineral Property Costs Mineral Permit (Assignment Agreement with Lithium Exploration VIII Ltd.) On December 16, 2010, the Company entered into an Assignment Agreement to acquire the following: a.) An undivided 100% right, title and interest in and to certain mineral permits located in the Province of Alberta, Canada. b.) All of the assignor’s right, title and interest in and to the Option Agreement. In consideration for the Assignment, the Company agreed to pay US$90,000 by way of cash or stock of equal value (consisting of amounts previously paid by the Assignor pursuant to the Option Agreement). The full $90,000 (consisting of option payments ‘i’ and ‘v’ below) was expensed and included in the December 31, 2011 accounts payable balance. The Option shall be in good standing and exercisable by the Company by paying the following amounts on or before the dates specified in the following schedule: i.) CDN $40,000 (paid) upon execution of the agreement; ii.) CDN $60,000 (paid) on or before January 1, 2012; iii.) CDN $100,000 on or before January 1, 2013 (amended and paid); iv.) CDN $300,000 on or before January 1, 2014 (not paid); and v.) Paying all such property payments as may be required to maintain the mineral permits in good standing. The Optionee shall provide a refundable amount of CDN$50,000 (paid) to the Optionor by November 2, 2010, which shall be applied by the Optionor towards work assessment expenses acceptable to the Government of Alberta, with any unused portion to be applied against payments required to maintain the permits underlying the property in good standing. On December 31, 2012, the Company entered into an agreement to amend the original payment requirement of CDN$100,000 due on January 1, 2013 to the following payments: CDN $20,000 (paid) cash payment due on January 1, 2013 and CDN $80,000 by a 15% one year promissory note starting January 1, 2013. The promissory note is interest free until March 31, 2013. After then, interest will accrue on the principal balance then in arrears at the rate of 15% per annum. No payments shall be payable until December 31, 2013. At any time, the Optionor may elect to convert the remaining balance of CDN $80,000 plus accrued interest into common shares of the Company at 75% of the closing market price of the Company’s common shares on the election day. The full CDN$100,000 (US$95,008) (consisting of cash payment of CDN$20,000 (US$19,164) and note payable of CDN$80,000 (US$75,844) was expensed. The note is subject to be measured at its fair value in accordance with ASC 480-10-25-14. The fair value at issuance was CDN$106,667 (US$101,125) as of June 30, 2013. An additional $26,667 was charged to mining expense during the year June 30, 2013. An interest expense of CDN$3,058 (US$2,899) was accrued as at June 30, 2013. On July 3, 2013, the Optionor elected to convert the promissory note of CDN $80,000 (US$75,844) plus accrued interest of CDN$3,058 (US$2,899) for the total amount of CDN $83,058 (US$78,743) into 239 common shares of the Company at a price of US$330 per share. The January 1, 2014 payment was not paid by the Company, and subsequent to the schedule payment date, the agreement was terminated. Glottech Technology On March 17, 2011 and subsequently amended on November 18, 2011, the Company entered into a letter agreement to acquire one initial unit of proprietary and patented mechanical ultrasound technology for use in water purification, inclusive of its process of separating from water, as the primary fluid stock, the salt and other minerals and by –products contained therein, with Glottech – USA. To acquire the unit, the Company must make the following payments: a) US$25,000 upon execution of the agreement (paid); b) US$75,000 within 180 days of execution of the agreement (paid); c) US$700,000 within 10 days of receipt of invoice from Glottech –USA LLC if the payment in b) is made (paid). d) The Company also granted an option to acquire 500 shares for $1.00 to Glottech – USA upon receipt of the operational ultrasonic generator that they are building for Lithium Exploration Group. The 500 shares are to be paid from outstanding shares owned by Alex Walsh, company CEO. During the year ended June 30, 2011, the option resulting in additional mining expenses of $4,940,000 was valued using the fair market value of the shares to be issued. On October 1, 2012, Alex Walsh and GD International entered into an agreement to transfer 500 common shares owned by Alex Walsh to GD International. The shares were received by GD International on October 29, 2012. Commencing as of the end of an initial sixty day testing and training period following satisfactory delivery and physical setup of the technology, and continuing thereafter for as long as the technology remains in the possession of the Company, the Company shall pay continuing monthly royalties in an amount equal to $2.00 per physical ton of water processed pursuant to the usage of the technology. On June 12, 2012, the Company filed a complaint with the court of common pleas of Chester County, Pennsylvania against Glottech – USA, LLC, Eldredge, Inc., and the Eldredge Companies, Inc. The complaint seeks an order of the court granting possession of the unit, in its current state, to the Company. Effective August 14, 2012, the Company entered into an option agreement with GD Glottech-International, Limited (“GD International”) to protect our license and distribution rights in the event that GD-Glottech-USA, LLC (“GD USA”) is unable to perform and honor the obligations contingent to a letter agreement dated November 8, 2011. Pursuant to the terms of the option agreement, we are required to provide an initial deposit of $150,000 to be held in escrow for the option to obtain a license on the patent rights, as set forth in the option agreement. A further $15,000 was required for exercising the option agreement and it will be credited to future fees when patents rights are exercised. We exerised this option agreement on September 1, 2012 and released the funds to GD International. On October 1, 2012, the Company entered into a sales agency agreement with GD International. The agreement shall replace all agreements entered previously. Pursuant to the agreement, the Company is appointed as GD International’s sales agent for the technology within the territory. As a consideration, 10,000 common shares of the Company shall be issued to GD International (issued: see d) above). GD International retains all right, title and interest in the technology. The term of this agreement will be an initial period of five years. The term shall be automatically renewable thereafter for successive five year periods provided that the Company has sold not less than 25 or more technology units during each applicable five year period. On May 2, 2013, the Company entered into an agreement to retain the future use of the unit. Pursuant to the agreement, the Company must make the following payments: a) US$20,000 within three days of execution of the agreement (paid); b) US$30,000 within three days upon the testing of the unit has been successfully completed. |
Convertible Promissory Notes
Convertible Promissory Notes | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes [Text Block] | 6. Convertible Promissory Notes Summary of convertible promissory note at December 31, 2015 and June 30, 2015 is as follows: June 30, Principal Total Total December 31, 2015 Issued converted repaid 2015 February 13, 2013 $ 67,913 $ - $ (18,680 ) $ - $ 49,233 March 15, 2014 29,394 - (22,755 ) - 6,639 July 22, 2014 540,498 - (46,408 ) - 494,090 August 22, 2014 37,243 - (5,200 ) - 32,043 February 6, 2015 75,000 - (20,000 ) - 55,000 February 24, 2015 100,000 - - 100,000 March 3, 2015 29,000 - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - 36,000 September 9, 2015 - 30,000 - - 30,000 September 30, 2015 - 27,000 - - 27,000 November 06,2015 - 12,000 - - 12,000 December 01, 2015 - 18,000 - - 18,000 December 01, 2015 - 18,000 - - 18,000 December 03, 2015 - 17,000 - - 17,000 $ 879,048 $ 158,000 $ (116,043 ) $ - $ 921,005 Less: Unamortized debt discount $ (345,054 ) $ (179,963 ) Total note payable, net of debt discount $ 533,994 $ 741,042 Current portion $ 533,994 $ 741,042 Long term portion $ - $ - On August 3, 2015 the Company issued an aggregate of $36,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $52,720 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17% The initial fair values of the embedded debt derivative of $33,231 was allocated as a debt discount up to the proceeds of the note with the remainder $19,489 was charged to current period operations as interest expense. On September 9, 2015, the Company issued an aggregate of $30,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $54,495 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39% The initial fair values of the embedded debt derivative $30,000 was allocated as a debt discount up to the proceeds of the note with the remainder $24,495 was charged to current period operations as interest expense. On September 30, 2015, Company issued an aggregate of $27,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear 10% interest per annum and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $306,808 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33% The initial fair values of the embedded debt derivative $27,000 was allocated as a debt discount up to the proceeds of the note with the remainder $279,808 was charged to current period operations as interest expense. On November 6, 2015, the Company issued an aggregate of $12,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $115,109 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 383.46% Risk free rate: 0.47% The initial fair values of the embedded debt derivative of $12,000 was allocated as a debt discount up to the proceeds of the note with the remainder $103,109 charged to operations as interest expense. On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense. On December 1, 2015, the Company issued an aggregate of $18,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $72,119 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% The initial fair values of the embedded debt derivative of $18,000 was allocated as a debt discount up to the proceeds of the note with the remainder $54,119 charged to operations as interest expense. On December 3, 2015, the Company issued an aggregate of $17,000 Convertible Promissory Notes that matures in a specified period from the date of issuance. These notes bear interest and is convertible into the Company’s common stock at any time at the holder’s option, at the conversion rate as specified in the terms of the note. The Company identified embedded derivatives related to the Convertible Promissory Notes. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the Convertible Promissory Note and to adjust the fair value as of each subsequent balance sheet date. At the inception of the Convertible Promissory Note, the Company determined a fair value of $27,706 of the embedded derivative. The fair value of the embedded derivative was determined using the Black Scholes Model based on the following assumptions: Dividend yield: 0% Volatility 394.55% Risk free rate: 0.57% The initial fair values of the embedded debt derivative of $17,000 was allocated as a debt discount up to the proceeds of the note with the remainder $10,706 charged to operations as interest expense. During the three and six months period ended December 31, 2015 the Company amortized the debt discount on all the notes of $149,379 and $320,322 to operations as interest expense, respectively. During the three and six months period ended December 31, 2014 the Company amortized the debt discount on all the notes of $875,252 and $1,584,896 to operations as interest expense, respectively. Derivative Liability- Debt The fair value of the described embedded derivative on all debt was valued at $1,015,698 and $1,646,448 at December 31, 2015 and June 30, 2015, respectively, which was determined using the Black Scholes Model with the following assumptions: December 31, 2015 June 30, 2015 Dividend yield: 0% 0% Volatility 314.39 - 459.51% 258.89% Risk free rate: . 49% - 1.06% . 11% - . 64% At December 31, 2015 and 2014, the Company adjusted the recorded fair value of the derivative liability on debt to market resulting in non-cash, non-operating gain of $1,070,492 and loss of $180,505 for the six months ended December 31, 2015 and 2014, respectively. And for the three months ending December 31, 2015 and December 31, 2014, the non-cash, non-operating gain of $8,660,230 and loss of $423,387 was recorded respectively. During the six months ended December 31, 2015 the Company issued 4,087,472 no of shares of the Company common stock in settlement of $116,043 of convertible note and interest. During the six months ended December 31, 2015 the Company reclassed the derivative liability debt of $261,331 to additional paid in capital on conversion of convertible note. The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2015 and June 30, 2015: Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,066,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2014 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 701,073 Fair value of liability at note conversion (261,331 ) Mark-to-market at December 31, 2015 (1,070,492 ) Balance, December 31, 2015 $ 1,015,698 Net gain for the period included in earnings relating to the liabilities held at December 31, 2015 $ 1,070,492 Derivative Liability- Warrants Along with the promissory notes, the Company issued warrants that bear a cashless exercise provision. The warrants also include anti-dilution protection with respect to lower priced issuances of common stock or securities convertible or exchangeable into common stock, which provision resulted in derivative liability treatment under ASC 480. The warrants are recorded at fair value using the Black-Scholes option pricing model and marked-to-market at each reporting period, with the changes in the fair value recorded in the consolidated statement of operations and comprehensive income (loss). During the six months ended December 31, 2015 no warrants were issued along with convertible note. The fair value of the described embedded derivative on all warrants was valued at $749,582 at December 31, 2015 and $143,375 at June 30, 2015 which was determined using the Black Scholes Model with the following assumptions: December 31, 2015 June 30, 2015 Dividend yield: 0% 0% Volatility 248,6% 288.96% Risk free rate: 1.31% – 1.76% 1.01% - 1.63% Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, December 31, 2015 27,092 $ 100.98 3.29 years The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of December 31, 2015 and June 30, 2015: Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2014 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at December 31, 2015 – warrant liability 606,206 Balance, December 31, 2015 $ 749,582 Net loss for the period included in earnings relating to the liabilities held at December 31, 2015 $ 749,582 At December 31, 2015 and 2014, the Company adjusted the recorded fair value of the derivative liability on warrants to market resulting in non-cash, non-operating loss of $606,206 and gain of $3,098,801 for the six months ended December 31, 2015 and 2014, respectively. Non-cash, non-operating gain of $245,829 and gain of $118,255 was recorded for the three months ended December 30, 2015 and December 30, 2014 respectively. During the six months ended December 31, 2015 the Company reclassed the derivative liability on warrants of $0 to additional paid in capital on exercise of warrants. |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Dec. 31, 2015 | |
Related Party Transactions [Text Block] | 7. Related Party Transactions During the six months ended December 31, 2015, the Company incurred consulting fees of $1,115 (June 30, 2015 - $157,086) with directors and officers out of which there were no stock payments (June 30, 2015 - $58,990 were paid by issuance of 2,167 shares of the Company common stock). As of December 31, 2015, the Company repaid to a director for a non-interest bearing demand loan of $nil (Note 9) (June 30, 2015 – payable $47,537). These transactions are in the normal course of operations and are measured at the exchange amount of consideration established and agreed to by the related parties. |
Going Concern and Liquidity Con
Going Concern and Liquidity Considerations | 6 Months Ended |
Dec. 31, 2015 | |
Going Concern and Liquidity Considerations [Text Block] | 8. Going Concern and Liquidity Considerations The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As at December 31, 2015, the Company had a working capital deficiency of $2,890,554 (June 30, 2015 - $2,456,477) and an accumulated deficit of $50,329,265 (June 30, 2015 - $49,504,350). The Company intends to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the next twelve months. The ability of the Company to emerge from the exploration stage is dependent upon, among other things, obtaining additional financing to continue operations, explore and develop the mineral properties and the discovery, development and sale of ore reserves. In response to these problems, management intends to raise additional funds through public or private placement offerings. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Dec. 31, 2015 | |
Commitments and Contingencies [Text Block] | 9. Commitments and Contingencies Employment Agreements On January 12, 2014, the Company entered into an employment agreement with a director and officer. Commencing on January 12, 2014, the director and officer will be employed for 24 months ending on January 12, 2016. Pursuant to the agreement, annual salary of US$120,000 is payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. Consulting Agreements On January 1, 2014, the Company entered in a consulting agreement with a consultants to provide services as members of the Board of Directors in regards to the Company’s management and operations. The compensation for the services to be provided will be $12,000 payable monthly in cash or if the Company does not have available cash, in shares of the Company’s common stock. The consulting agreement was amended on October 22, 2014 to include an additional aggregate of $30,000 payable as of October 22, 2014 in cash or in shares of the Company’s common stock, and changed the term of agreement from 12 months to 10 months. Effective November 1, 2014, the consultant resigned as member of the Board of Directors. On April 28, 2014, the Company entered into a consulting agreement with a consultant to provide services as members of the Board of Directors in regards to the Company’s management and operations. Pursuant to the terms of the agreement, the consultant will receive compensation of $12,000 in unregistered restricted common shares of the Company's common stock at a deemed value of $200.0 per share, issuable on May 15, 2014, effective April 28, 2014 to April 27, 2015. The consultant resigned as member of the Board of Directors and these shares were not issued. On May 30, 2014, the Company entered into a consulting agreement with a consultant to provide services as member of the Board of Directors in regards to the Company’s management and operation. The compensation for the services to be provided will be $10,000 per month payable in common stock of the Company from a period of six months from the effective date of May 30, 2014. On August 1, 2014, the Company entered into a consulting agreement with a consultant to provide advice relative to corporate and business services and to perform other related activities. Pursuant to the terms of the agreement, the Company will issue 500 common shares of the Company valued at $68,000. These shares were issued in full effective October 22, 2014. Lease Commitment On May 15, 2014, the Company entered into a sublease agreement for a term of twenty four and one half months and expiring on May 31, 2016. Future minimum rental payments required under operating lease (exclusive of other additional rent payments) are $13,656. Litigation From time to time we may be a defendant and plaintiff in various other legal proceedings arising in the normal course of our business. Except as disclosed above, we are currently not a party to any material legal proceedings or government actions, including any bankruptcy, receivership, or similar proceedings. In addition, we are not aware of any known litigation or liabilities involving the operators of our properties that could affect our operations. Furthermore, as of the date of this Annual Report, our management is not aware of any proceedings to which any of our directors, officers, or affiliates, or any associate of any such director, officer, affiliate, or security holder is a party adverse to our company or has a material interest adverse to us. |
Loan Receivable
Loan Receivable | 6 Months Ended |
Dec. 31, 2015 | |
Loan Receivable [Text Block] | 10. Loan Receivable Secured Bridge Loan Agreement On December 18, 2013, the Company entered into an agreement with GD Glottech International Ltd (“GDGI”) whereby the Company loaned to GDGI the sum of $20,000. GDGI will repay the total amount of the loan plus interest in the amount of $333.34 (representing a 10% annual interest rate), within sixty (60) days from the receipt of the loan funds or within five (5) days of Sonic Cavitation, LLC receiving a 5% Capital Contribution. On April 21, 2014, the Company entered into an amended agreement with Sonic Cavitation, whereby Sonic Cavitation agreed to facilitate the construction of one sonic cavitation generator. The Company agreed to pay Sonic Cavitation a consulting fee of $20,000 upon execution of the agreement and forgive the sum of $20,000 debt upon delivery of the prototype by Sonic Cavitation. The agreement has been executed, however the delivery of the prototype has not yet fulfilled. During the six months ending December 31, 2015, the directors of the company decided that the loan is irrecoverable and has been written off to $nil. |
Discontinued Operations
Discontinued Operations | 6 Months Ended |
Dec. 31, 2015 | |
Discontinued Operations [Text Block] | 11. Discontinued Operations On September 4, 2015, the Company entered into an Asset Purchase agreement whereby the Company sells the net assets of Alta Disposal Morinville Ltd. (of which the Company had acquired 51% interest on October 18, 2013) for total purchase price of CDN$10,000. Operating results for the period ended December 31, 2015 and 2014 for Alta Disposal Morinville Ltd. are presented as discontinued operations and the assets and liabilities classified as held for sale are presented separately in the consolidated balance sheet. A breakdown of the discontinued operations is presented as follow: Consolidated Statements of Operations and Comprehensive Loss December 31, December 2015 31, 2014 Revenue $ - $ 41,300 Selling, general and administrative $ (78,570 ) (323,187 ) Loss from discontinued operations $ (78,570 ) $ (281,887 ) Consolidated Balance Sheets December 31, June 30, 2015 2015 Current assets: Cash and cash equivalents $ 1,189 $ 46,731 Receivable, net 7,016 28,160 Prepaid expenses - - GST Receivable 14,931 - Impairment of net assets - (60,178 ) $ 23,136 14,713 Current liabilities: Accounts payable $ 6,034 $ 6,696 |
Subsequent Events
Subsequent Events | 6 Months Ended |
Dec. 31, 2015 | |
Subsequent Events [Text Block] | 12. Subsequent Events On January 27, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $5,500, with an issuance discount of $500 and maturity of one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On January 27, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $24,750, with an issuance discount of $2,250 and legal fees of $2,500. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. On March 1, 2016, the Company entered into an agreement with an investor. Pursuant to the terms of the agreement, the investor acquired a 10% convertible note with an aggregate face value of $13,200, with an issuance discount of $1,200 and $2,000 of legal fees. The note matures in one year. The holder of this note is entitled, at its option, to convert all or a part of the principal outstanding at the date into shares of the company’s common stock. Subsequent to the issuance of June 30, 2015 financial statements, management determined that the warrants issued were incorrectly valued and derivative liability on the conversion option embedded in convertible notes was not recognized and during the six months period ending December 31, 2015, these warrants were revalued and a derivative liability on the conversion option was calculated. As a result of revaluation of the warrants, the consolidated balance sheet for the year ending June 30, 2015, the consolidated statements of operations and comprehensive income (loss) and consolidated statement of cash flows for the six months period ending December 31, 2014 and consolidated statements of changes in stockholders’ deficit for the period ending June 30, 2014 and June 30, 2015 were restated. The Company has evaluated subsequent events from January 1, 2016, through the date of this report, and determined there are no other items to disclose. |
Restatement to previously issue
Restatement to previously issued financial statements | 6 Months Ended |
Dec. 31, 2015 | |
Restatement to previously issued financial statements [Text Block] | 13. Restatement to previously issued financial statements The following tables reflect the corrections to the affected line items in the previously issued financial statements as of and for the years ended June 30, 2015 and for the period ended December 31, 2014. Effect on Condensed Consolidated Balance Sheet Year ended June 30, 2015 As previously Effect of As Restated reported Restatement ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,099 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,021 Total Assets $ 115,021 $ - $ 115,021 LIABILITIES Current Accounts payable and accrued liabilities (note 9) $ 65,962 $ - $ 65,962 Derivative liability – warrants (Note 6) 3,134 140,241 143,375 Derivative liability – convertible promissory notes (Note 6) - 1,646,448 1,646,448 Due to related party (Note 7 and 9) 115,000 - 115,000 Convertible promissory notes (Note 6) 300,887 233,107 533,994 Accrued interest – convertible promissory notes (Note 6) 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,019,796 $ 2,571,497 STOCKHOLDERS’ DEFICIT Capital stock (Note 3) Issued and outstanding: - - - 7,574,353 common shares 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,026 ) Non-controlling interest (313,450 ) - (313,450 ) Total Stockholders’ Deficit (436,680 ) (2,019,796 ) (2,456,476 ) Total Liabilities and Stockholders’ Deficit $ 115,021 $ - $ 115,021 Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) Six months ended December 31, 2014 As previously Effect of reported Restatement As Restated Revenue $ 41,300 $ (41,300 ) $ - Operating Expenses: Mining (Notes 3 & 5) 15,000 - 15,000 Selling, general and administrative (Notes 3 & 5) 908,916 (323,188 ) 585,728 Total operating expenses 923,916 (323,188 ) 600,728 (Loss) from operations (882,616 ) (281,888 ) (600,728 ) Other income (expenses) Interest expense (Note 6) (2,671,540 ) 1,635,637 (1,035,903 ) Gain on change in the fair value of derivative liability (Note 6) 2,818,577 99,720 2,918,297 Fair Value of Warrants issued (97,070 ) (97,070 ) - Amortization of discount on debt discount - (1,584,896 ) (1,584,896 ) Equity in income of investment held for sale 6,145 - 6,145 (Loss) before income taxes (826,504 ) 529,419 (297,085 ) Provision for Income Taxes (Note 4) - - - (Loss) from continuing operations (826,504 ) 529,419 (297,085 ) (Loss) from discontinued operations - (281,887 ) (281,887 ) Net (loss) (826,504 ) 247,532 (578,972 ) Less: Net (loss) attributable to the non-controlling interest (138,125 ) - (138,125 ) Net (loss) attributable to Lithium Exploration Group, Inc. Common shareholders $ (688,379 ) $ 247,532 $ (440,847 ) Basic and Diluted (loss) per Common Share 0.00 (3.22 ) (3.22 ) Basic and Diluted Weighted Average Number of Common Shares Outstanding 547,109,178 (546,972,401 ) 136,777 Comprehensive (loss) : Net (loss) (826,504 ) 247,532 (578,972 ) Foreign currency translation adjustment (7,834 ) - (7,834 ) Comprehensive (loss) (834,338 ) 247,532 (586,806 ) Comprehensive (loss) attributable to non-controlling interest (138,125 ) - (138,125 ) Comprehensive (loss) attributable to Lithium Exploration Group, Inc. $ (696,213 ) $ 247,532 $ (448,681 ) Effect on Condensed Consolidated Statements of Cash Flows Six months ending December 31, 2014 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net (loss) from continuing operations $ (826,504 ) $ 529,419 $ (297,085 ) (Loss) from discontinued operations - (281,887 ) (281,887 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale (6,145 ) - (6,145 ) Common shares issued for consulting fees 118,990 - 118,990 Interest expense 2,544,024 (1,635,637 ) 908,387 Amortization of discount on derivative liabilities - 1,584,896 1,584,896 Bad debt written-off - - - Common shares issued for interest expenses 99,567 - 99,567 Gain on change in the fair value of derivative liability (2,818,577 ) 99,720 (2,918,297 ) Fair value of warrants issued 97,070 (97,070 ) - Changes in operating assets and liabilities: Receivable, net (1,749 ) 1,749 - Prepaid expenses 19,074 (2,464 ) 16,610 Accrued interest 27,949 - 27,949 Accounts payable and accrued liabilities 62,497 (28,812 ) 33,685 Net cash used in operating activities from continuing operations (683,804 ) (29,527 ) (713,331 ) Net cash provided by operating activities from discontinued operations - 15,779 15,779 Net cash used in operating activities (683,804 ) (13,748 ) (697,552 ) Cash Flows from Financing Activities Repayment of related party (45,332 ) - (45,332 ) Proceed from issuance of convertible promissory notes 750,000 - 750,000 Net cash provided by financing activities 704,668 - 704,668 Effect of foreign exchange (7,834 ) - (7,834 ) Increase (decrease) in cash and cash equivalents 13,030 (13,746 ) (718 ) Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 82,762 $ (25,846 ) $ 59,914 Supplementary disclosure of cash flow information: Cash paid during the period for: Interest $ 2,205 (2,205 ) $ - Income taxes $ - $ - Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 2,493,048 $ (1,018,846 ) $ 1,474,202 Transfer of beneficial conversion feature to fair value of note $ 408,962 $ (408,962 ) $ - Common stock issued on cashless exercise of warrants $ 766,675 $ 1,605,259 $ 2,371,934 Derivative liability re-classed to additional paid in capital $ - $ 2,286,445 $ 2,286,445 Debt discount on convertible note and warrants $ - $ 743,481 $ 743,481 Initial derivative liability on note issuance $ - $ 1,642,368 $ 1,642,368 Effect on Condensed Consolidated Statements of Changes in Stockholders’ Deficit Year ended June 30, 2015 As previously Misstatement As Restated reported Adjustment Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net Income (Loss) for the year (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net Income (Loss) for the year (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 ) |
Summary of Significant Accounti
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Dec. 31, 2015 | |
Basis of presentation and consolidation [Policy Text Block] | Basis of presentation and consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These interim financial statements as of and for the six months ended December 31, 2015 and 2014 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations and cash flows of the Company for the periods presented. The results for the six months ended December 31, 2015 are not necessarily indicative of the results to be expected for the year ending June 30, 2016 or for any future period. All references to Dec 31, 2015 and 2014 in these footnotes are unaudited. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended June 30, 2015, included in the Company’s annual report on Form 10-K filed with the SEC on December 3, 2015. The condensed balance sheet as of June 30, 2015 was restated during the period ending December 31, 2015 and has been carried forward for the period ending December 31, 2015, and do not include all disclosures required by the accounting principles generally accepted in the United States of America. |
Principal of Consolidation [Policy Text Block] | Principal of Consolidation The consolidated financial statements include the accounts of the Company, its wholly-owned subsidiary Alta Disposal Ltd. and its 51% owned subsidiary Alta Disposal Morinville Ltd. (formerly Bluetap Resources Ltd.). Intercompany accounts and transactions have been eliminated in consolidation in conformity with the applicable accounting framework. |
Use of Estimates [Policy Text Block] | Use of Estimates The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company. Significant estimates that may materially change in the near term include the valuation of derivative liabilities and the underlying warrants, as well as fair value of investments. |
Cash and Cash Equivalents [Policy Text Block] | Cash and Cash Equivalents Cash and cash equivalents include cash in banks, money market funds, and certificates of term deposits with original maturities of less than three months, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. The Company had $13,796 and $64,098 in cash and cash equivalents at December 31, 2015 and June 30, 2015, respectively. |
Concentration of Risk [Policy Text Block] | Concentration of Risk The Company maintains cash balances at a financial institution which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits for banks located in the US. As of December 31, 2015 and June 30, 2015, the Company had $Nil and $Nil, respectively, in deposits in excess of federally insured limits in its US bank. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash in bank accounts. |
Prepaid expenses [Policy Text Block] | Prepaid expenses Prepaid expenses consist of security deposit for office lease which will be expensed or refunded at the end of the lease period. |
Start-Up Costs [Policy Text Block] | Start-Up Costs In accordance with FASC 720-15-20 “ Start-Up Costs,” |
Mineral Acquisition and Exploration Costs [Policy Text Block] | Mineral Acquisition and Exploration Costs The Company has been in the exploration stage since its formation on May 31, 2006. It is primarily engaged in the acquisition, exploration, and development of mining properties. Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserves. |
Concentrations of Credit Risk [Policy Text Block] | Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. |
Net Income or (Loss) per Share of Common Stock [Policy Text Block] | Net Income or (Loss) per Share of Common Stock The Company has adopted FASC Topic No. 260, “ Earnings Per Share Potentially dilutive securities are not presented in the computation of EPS since their effects are anti-dilutive. |
Foreign Currency Translations [Policy Text Block] | Foreign Currency Translations The Company’s functional and reporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchange rate prevailing on the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date. Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income or loss. Upon realization, the amount deferred is recognized in income in the period when it is realized. Translation of Foreign Operations The financial results and position of foreign operations whose functional currency is different from the Company’s presentation currency are translated as follows: Exchange differences arising on translation of foreign operations are transferred directly to the Company’s accumulated other comprehensive loss in the consolidated balance sheets. Transaction gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the consolidated statements of operations. The relevant translation rates are as follows: For the period ending December 31, 2015 closing rate at 0.7225 CDN$: US$, average rate at 0.7565 CDN$: US$ and for the year ended June 30, 2015 closing rate at 0.8017 CDN$: US$, average rate at 0.8518 CDN$: US$. |
Comprehensive Income (Loss) [Policy Text Block] | Comprehensive Income (Loss) FASC Topic No. 220, “ Comprehensive Income,” |
Risks and Uncertainties [Policy Text Block] | Risks and Uncertainties The Company operates in the resource exploration industry that is subject to significant risks and uncertainties, including financial, operational, technological, and other risks associated with operating a resource exploration business, including the potential risk of business failure. |
Environmental Expenditures [Policy Text Block] | Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time in varying degree by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company's policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. |
Warrants [Policy Text Block] | Warrants The Company accounts for currently outstanding detachable warrants to purchase common stock as derivative liabilities as they are freestanding derivative financial instruments. The warrants are recorded as derivative liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative liabilities recorded in the condensed consolidated statements of operations and comprehensive Income (Loss). |
Convertible Instruments [Policy Text Block] | Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 815 “Derivatives and Hedging”. It provide three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of notes redemption |
Fair Value of Financial Instruments [Policy Text Block] | Fair Value of Financial Instruments ASC 820, “Fair Value Measurements and Disclosures” Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, prepaid expenses, deposit, accounts payable and accrued liabilities, and due to a related party approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the liability of the Company’s secured convertible promissory notes and debentures issued to investors, and the derivative warrants issued in connection with these convertible promissory notes and debentures. There is no current market for these securities such that the determination of fair value requires significant judgment or estimation. The Company used a fair value model which incorporates transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date. |
Revenue Recognition [Policy Text Block] | Revenue Recognition The Company has generated little revenues to date. It is the Company’s policy that revenue from product sales or services will be recognized in accordance with ASC 605 “Revenue Recognition”. Four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are recorded. The Company will defer any revenue for which the product/services was not delivered or is subject to refund until such time that the Company and the customer jointly determine that the product/service has been delivered or no refund will be required. Sales comprise the fair value of the consideration received or receivable for the sale of goods and rendering of services in the ordinary course of the Company’s activities. Sales are presented, net of tax, rebates and discounts, and after eliminating intercompany sales. The Company recognizes revenue when the amount of revenue and related cost can be reliably measured and it is probable that the collectability of the related receivables is reasonably assured. |
Income Taxes [Policy Text Block] | Income Taxes The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes. Deferred taxes are provided in the financial statements under FASC 740-20-20 to give effect to the resulting temporary differences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costs based on the income taxes expected to be payable in future years. |
Receivables [Policy Text Block] | Receivables Trade and other receivables are customer obligations due under normal trade terms and are recorded at face value less any provisions for uncollectible amounts considered necessary. The Company includes any balances that are determined to be uncollectible in its overall allowance for doubtful accounts. The Company recorded $Nil (June 30, 2015 - $18,984) in allowance for doubtful accounts. |
Recent Accounting Pronouncements [Policy Text Block] | Recent Accounting Pronouncements In August 2015, the FASB issued ASU 2015-15 “Interest – Imputation of Interest (Subtopic 835-30) – Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements (Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting).” The guidance issued previously in ASU 2015-03 did not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within ASU 2015-03, the SEC staff stated that they would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. In September 2015, the FASB issued ASU 2015-16 an update to its guidance on business combinations. The new guidance requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the measurement amounts are determined. The new guidance also requires that the acquirer records, in the same period’s financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed as of the acquisition date. The new guidance also requires an entity to present separately on the face of the income statement, or disclose in the notes, the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. The Company does not anticipate a material impact to the Company’s financial statements as a result of the amendments. |
FASB Statements [Policy Text Block] | FASB Statements: In June 2009 the FASB established the Accounting Standards Codification ("Codification" or "ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States ("GAAP"). Rules and interpretive releases of the Securities and Exchange Commission ("SEC") issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Existing GAAP was not intended to be changed as a result of the Codification, and accordingly the change did not impact our financial statements. The ASC does change the way the guidance is organized and presented. Accounting Standards Updates ("ASUs") through ASU No. 2014-08 which contain technical corrections to existing guidance or affect guidance to specialized industries or entities were recently issued. These updates have no current applicability to the Company or their effect on the financial statements would not have been significant. |
Provision For Income Taxes (Tab
Provision For Income Taxes (Tables) | 6 Months Ended | |
Dec. 31, 2015 | Dec. 31, 2014 | |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | For the six months ended December 31, 2015 Amount Tax Effect (35% Net loss $ 784,846 $ 274,696 Shares issued for consulting fees, mining expenses, investor relation and director fees Interest Expense (545,832 ) (191,041 ) Gain on derivative liability 464,286 162,500 Amortization of discount (320,322 ) (112,113 ) Impairment (7,565 ) (2,648 ) Total 390,542 136,690 Valuation allowance (390,542 ) (136,690 ) Net deferred tax asset (liability) $ - $ - | For the six months ended December 31, 2014 Amount Tax Effect ( 35%) Net loss $ 297,085 $ 103,980 Shares issued for consulting fees, mining expenses, investor relation and director fees (118,990 ) (41,647 ) Shares issued for interest expenses (99,567 ) (34,849 ) Amortization of discount (1,584,896 ) (554,714 ) Interest Expense (898,887 ) (314,610 ) Gain on derivative liability 2,918,297 1,021,404 Total 513,042 179,565 Valuation allowance (513,042 ) (179,565 ) Net deferred tax asset (liability) $ - $ - |
Convertible Promissory Notes (T
Convertible Promissory Notes (Tables) | 6 Months Ended |
Dec. 31, 2015 | |
Schedule of Summary of Convertible Promissory Note [Table Text Block] | June 30, Principal Total Total December 31, 2015 Issued converted repaid 2015 February 13, 2013 $ 67,913 $ - $ (18,680 ) $ - $ 49,233 March 15, 2014 29,394 - (22,755 ) - 6,639 July 22, 2014 540,498 - (46,408 ) - 494,090 August 22, 2014 37,243 - (5,200 ) - 32,043 February 6, 2015 75,000 - (20,000 ) - 55,000 February 24, 2015 100,000 - - 100,000 March 3, 2015 29,000 - (3,000 ) - 26,000 August 3, 2015 - 36,000 - - 36,000 September 9, 2015 - 30,000 - - 30,000 September 30, 2015 - 27,000 - - 27,000 November 06,2015 - 12,000 - - 12,000 December 01, 2015 - 18,000 - - 18,000 December 01, 2015 - 18,000 - - 18,000 December 03, 2015 - 17,000 - - 17,000 $ 879,048 $ 158,000 $ (116,043 ) $ - $ 921,005 Less: Unamortized debt discount $ (345,054 ) $ (179,963 ) Total note payable, net of debt discount $ 533,994 $ 741,042 Current portion $ 533,994 $ 741,042 Long term portion $ - $ - |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On August 03, 2015 [Table Text Block] | Dividend yield: 0% Volatility 269.35% Risk free rate: 0.17% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 09, 2015 [Table Text Block] | Dividend yield: 0% Volatility 275.84% Risk free rate: 0.39% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 30, 2015 [Table Text Block] | Dividend yield: 0% Volatility 375.79% Risk free rate: 0.33% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On November 6, 2015 [Table Text Block] | Dividend yield: 0% Volatility 383.46% Risk free rate: 0.47% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On December 1, 2015 [Table Text Block] | Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% |
Schedule of Stock Options, Valuation Assumptions AS On December 1, 2015 With Aggregate $18,000 Convertible Promissory Notes [Table Text Block] | Dividend yield: 0% Volatility 392.28% Risk free rate: 0.51% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On December 3, 2015 [Table Text Block] | Dividend yield: 0% Volatility 394.55% Risk free rate: 0.57% |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | December 31, 2015 June 30, 2015 Dividend yield: 0% 0% Volatility 314.39 - 459.51% 258.89% Risk free rate: . 49% - 1.06% . 11% - . 64% |
Schedule of Changes in Fair Value of Convertible Promissory Notes [Table Text Block] | Derivative Liability (convertible promissory notes) Balance, June 30, 2014 $ 3,066,171 Initial fair value at note issuances 1,227,384 Fair value of liability at note conversion (3,174,990 ) Mark-to-market at June 30, 2014 527,883 Balance, June 30, 2015 $ 1,646,448 Initial fair value at note issuances 701,073 Fair value of liability at note conversion (261,331 ) Mark-to-market at December 31, 2015 (1,070,492 ) Balance, December 31, 2015 $ 1,015,698 Net gain for the period included in earnings relating to the liabilities held at December 31, 2015 $ 1,070,492 |
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block] | December 31, 2015 June 30, 2015 Dividend yield: 0% 0% Volatility 248,6% 288.96% Risk free rate: 1.31% – 1.76% 1.01% - 1.63% |
Schedule of Stockholders' Equity Warrants Activity [Table Text Block] | Warrants Weighted Weighted Outstanding Average Average Exercise Remaining Price life Balance, June 30, 2014 15,204 $ 242.57 2.62 years Warrants issued 19,104 236.92 4.46 years Exercised (5,927 ) 257.08 - Cancelled - - - Expired (1,289 ) 240.00 - Balance, June 30, 2015 27,092 $ 100.98 3.79 years Warrants issued - - - Exercised - - - Cancelled - - - Expired - - - Balance, December 31, 2015 27,092 $ 100.98 3.29 years |
Schedule of Changes in Fair Value of Financial Liabilities [Table Text Block] | Derivative Liability (warrants) Balance, June 30, 2014 $ 5,416,000 Initial fair value of warrant derivatives at note issuances 791,407 Fair value of warrant exercised (2,730,022 ) Mark-to-market at June 30, 2014 – warrant liability (3,334,009 ) Balance, June 30, 2015 $ 143,376 Initial fair value of warrant derivatives at note issuances - Fair value of warrant exercised - Mark-to-market at December 31, 2015 – warrant liability 606,206 Balance, December 31, 2015 $ 749,582 Net loss for the period included in earnings relating to the liabilities held at December 31, 2015 $ 749,582 |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 6 Months Ended |
Dec. 31, 2015 | |
Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss [Table Text Block] | December 31, December 2015 31, 2014 Revenue $ - $ 41,300 Selling, general and administrative $ (78,570 ) (323,187 ) Loss from discontinued operations $ (78,570 ) $ (281,887 ) |
Schedule of Discontinued Operations, Consolidated Balance Sheets [Table Text Block] | Consolidated Balance Sheets December 31, June 30, 2015 2015 Current assets: Cash and cash equivalents $ 1,189 $ 46,731 Receivable, net 7,016 28,160 Prepaid expenses - - GST Receivable 14,931 - Impairment of net assets - (60,178 ) $ 23,136 14,713 Current liabilities: Accounts payable $ 6,034 $ 6,696 |
Restatement to previously iss24
Restatement to previously issued financial statements (Tables) | 6 Months Ended |
Dec. 31, 2015 | |
Schedule of Effect on Condensed Consolidated Balance Sheet [Table Text Block] | Year ended June 30, 2015 As previously Effect of As Restated reported Restatement ASSETS Current Cash and cash equivalents $ 64,099 $ - $ 64,099 Receivable 13,421 - 13,421 Loan receivable 20,000 - 20,000 Prepaid expenses 2,788 - 2,788 Current assets held for sale 14,713 - 14,713 Total current assets 115,021 - 115,021 Total Assets $ 115,021 $ - $ 115,021 LIABILITIES Current Accounts payable and accrued liabilities (note 9) $ 65,962 $ - $ 65,962 Derivative liability – warrants (Note 6) 3,134 140,241 143,375 Derivative liability – convertible promissory notes (Note 6) - 1,646,448 1,646,448 Due to related party (Note 7 and 9) 115,000 - 115,000 Convertible promissory notes (Note 6) 300,887 233,107 533,994 Accrued interest – convertible promissory notes (Note 6) 60,022 - 60,022 Liabilities of discontinued operations 6,696 - 6,696 Total Current Liabilities $ 551,701 $ 2,019,796 $ 2,571,497 STOCKHOLDERS’ DEFICIT Capital stock (Note 3) Issued and outstanding: - - - 7,574,353 common shares 7,575 - 7,575 Additional paid-in capital 43,165,743 4,217,489 47,383,232 Accumulated other comprehensive loss (29,484 ) - (29,484 ) Deficit accumulated during the exploration (43,267,064 ) (6,237,285 ) (49,504,349 ) Total Lithium Exploration Group, Inc. Stockholders’ Deficit (123,230 ) (2,019,796 ) (2,143,026 ) Non-controlling interest (313,450 ) - (313,450 ) Total Stockholders’ Deficit (436,680 ) (2,019,796 ) (2,456,476 ) Total Liabilities and Stockholders’ Deficit $ 115,021 $ - $ 115,021 |
Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) [Table Text Block] | Six months ended December 31, 2014 As previously Effect of reported Restatement As Restated Revenue $ 41,300 $ (41,300 ) $ - Operating Expenses: Mining (Notes 3 & 5) 15,000 - 15,000 Selling, general and administrative (Notes 3 & 5) 908,916 (323,188 ) 585,728 Total operating expenses 923,916 (323,188 ) 600,728 (Loss) from operations (882,616 ) (281,888 ) (600,728 ) Other income (expenses) Interest expense (Note 6) (2,671,540 ) 1,635,637 (1,035,903 ) Gain on change in the fair value of derivative liability (Note 6) 2,818,577 99,720 2,918,297 Fair Value of Warrants issued (97,070 ) (97,070 ) - Amortization of discount on debt discount - (1,584,896 ) (1,584,896 ) Equity in income of investment held for sale 6,145 - 6,145 (Loss) before income taxes (826,504 ) 529,419 (297,085 ) Provision for Income Taxes (Note 4) - - - (Loss) from continuing operations (826,504 ) 529,419 (297,085 ) (Loss) from discontinued operations - (281,887 ) (281,887 ) Net (loss) (826,504 ) 247,532 (578,972 ) Less: Net (loss) attributable to the non-controlling interest (138,125 ) - (138,125 ) Net (loss) attributable to Lithium Exploration Group, Inc. Common shareholders $ (688,379 ) $ 247,532 $ (440,847 ) Basic and Diluted (loss) per Common Share 0.00 (3.22 ) (3.22 ) Basic and Diluted Weighted Average Number of Common Shares Outstanding 547,109,178 (546,972,401 ) 136,777 Comprehensive (loss) : Net (loss) (826,504 ) 247,532 (578,972 ) Foreign currency translation adjustment (7,834 ) - (7,834 ) Comprehensive (loss) (834,338 ) 247,532 (586,806 ) Comprehensive (loss) attributable to non-controlling interest (138,125 ) - (138,125 ) Comprehensive (loss) attributable to Lithium Exploration Group, Inc. $ (696,213 ) $ 247,532 $ (448,681 ) |
Schedule of Effect on Condensed Consolidated Statements of Cash Flows [Table Text Block] | Six months ending December 31, 2014 As previously Misstatement As Restated reported Adjustment Cash Flows from Operating Activities Net (loss) from continuing operations $ (826,504 ) $ 529,419 $ (297,085 ) (Loss) from discontinued operations - (281,887 ) (281,887 ) Adjustments to reconcile net loss to net cash used in operating activities: Equity in income of investment held for sale (6,145 ) - (6,145 ) Common shares issued for consulting fees 118,990 - 118,990 Interest expense 2,544,024 (1,635,637 ) 908,387 Amortization of discount on derivative liabilities - 1,584,896 1,584,896 Bad debt written-off - - - Common shares issued for interest expenses 99,567 - 99,567 Gain on change in the fair value of derivative liability (2,818,577 ) 99,720 (2,918,297 ) Fair value of warrants issued 97,070 (97,070 ) - Changes in operating assets and liabilities: Receivable, net (1,749 ) 1,749 - Prepaid expenses 19,074 (2,464 ) 16,610 Accrued interest 27,949 - 27,949 Accounts payable and accrued liabilities 62,497 (28,812 ) 33,685 Net cash used in operating activities from continuing operations (683,804 ) (29,527 ) (713,331 ) Net cash provided by operating activities from discontinued operations - 15,779 15,779 Net cash used in operating activities (683,804 ) (13,748 ) (697,552 ) Cash Flows from Financing Activities Repayment of related party (45,332 ) - (45,332 ) Proceed from issuance of convertible promissory notes 750,000 - 750,000 Net cash provided by financing activities 704,668 - 704,668 Effect of foreign exchange (7,834 ) - (7,834 ) Increase (decrease) in cash and cash equivalents 13,030 (13,746 ) (718 ) Cash and cash equivalents - beginning of period 69,732 (12,100 ) 57,632 Cash and cash equivalents - end of period $ 82,762 $ (25,846 ) $ 59,914 Supplementary disclosure of cash flow information: Cash paid during the period for: Interest $ 2,205 (2,205 ) $ - Income taxes $ - $ - Supplementary non- cash Investing and Financing Activities: Non-cash investing and financing activities Common stock issued for debt conversion $ 2,493,048 $ (1,018,846 ) $ 1,474,202 Transfer of beneficial conversion feature to fair value of note $ 408,962 $ (408,962 ) $ - Common stock issued on cashless exercise of warrants $ 766,675 $ 1,605,259 $ 2,371,934 Derivative liability re-classed to additional paid in capital $ - $ 2,286,445 $ 2,286,445 Debt discount on convertible note and warrants $ - $ 743,481 $ 743,481 Initial derivative liability on note issuance $ - $ 1,642,368 $ 1,642,368 |
Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit [Table Text Block] | Year ended June 30, 2015 As previously Misstatement As Restated reported Adjustment Additional Paid in Capital Beginning Balance $ 38,573,856 $ 538,043 $ 39,111,899 Common shares issued for debt conversion 3,636,984 (1,457,586 ) 2,179,398 Common shares issued for exercise of warrants 767,879 1,962,041 2,729,920 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Closing Balance $ 43,165,743 $ 4,217,488 $ 47,383,231 Accumulated deficit Beginning Balance $ (40,821,871 ) $ (6,166,108 ) $ (46,987,979 ) Net Income (Loss) for the year (2,445,193 ) (71,176 ) (2,516,369 ) Closing Balance $ (43,267,064 ) $ (6,237,283 ) $ (49,504,347 ) Total Equity Beginning Balance $ (2,355,136 ) $ (5,628,065 ) $ (7,983,201 ) Common shares issued for consulting fees 118,990 118,990 Common shares issued for investor relations 68,000 68,000 Common shares issued for exercise of warrants 767,981 1,962,039 2,730,020 Common shares issued for debt conversion 3,644,405 (1,457,585 ) 2,186,820 Common shares issued for reclassification of derivative liability on convertible notes - 3,174,990 3,174,990 Common shares issued to trust 38 - 38 Foreign exchange translation (23,715 ) (23,715 ) Net Income (Loss) for the year (2,657,243 ) (71,176 ) (2,728,419 ) Closing Balance $ (436,680 ) $ (2,019,797 ) $ (2,456,477 ) |
Organization (Narrative) (Detai
Organization (Narrative) (Details) | 6 Months Ended | |
Dec. 31, 2015USD ($) | Dec. 31, 2015CAD | |
Organization 1 | 1,617,437 | 1,617,437 |
Organization 2 | 51.00% | 51.00% |
Organization 3 | CAD | CAD 10,000 | |
Organization 4 | $ | $ 7,466 | |
Organization 5 | 100.00% | 100.00% |
Organization 6 | 50.00% | 50.00% |
Organization 7 | 50.00% | 50.00% |
Organization 8 | 20 | 20 |
Organization 9 | 50.00% | 50.00% |
Organization 10 | 100.00% | 100.00% |
Significant Accounting Polici26
Significant Accounting Policies (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Significant Accounting Policies 1 | 51.00% |
Significant Accounting Policies 2 | $ 13,796 |
Significant Accounting Policies 3 | 64,098 |
Significant Accounting Policies 4 | 0 |
Significant Accounting Policies 5 | $ 0 |
Significant Accounting Policies 6 | 0.7225 |
Significant Accounting Policies 7 | 0.7565 |
Significant Accounting Policies 8 | 0.8017 |
Significant Accounting Policies 9 | 0.8518 |
Significant Accounting Policies 10 | $ 0 |
Significant Accounting Policies 11 | $ 18,984 |
Capital Stock (Narrative) (Deta
Capital Stock (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)yr$ / sharesshares | |
Capital Stock 1 | 20 |
Capital Stock 2 | 1 |
Capital Stock 3 | 200 |
Capital Stock 4 | 1 |
Capital Stock 5 | 2,333,973,894 |
Capital Stock 6 | 11,669,869 |
Capital Stock 7 | 100,000,000 |
Capital Stock 8 | 100,000,000 |
Capital Stock 9 | $ / shares | $ 0.001 |
Capital Stock 10 | 600,000,000 |
Capital Stock 11 | 500,000,000 |
Capital Stock 12 | $ / shares | $ 0.001 |
Capital Stock 13 | 100,000,000 |
Capital Stock 14 | $ / shares | $ 0.001 |
Capital Stock 15 | 20,000,000 |
Capital Stock 16 | $ / shares | $ 0.001 |
Capital Stock 17 | $ / shares | $ 100 |
Capital Stock 18 | $ | $ 0.001 |
Capital Stock 19 | 2,000,000 |
Capital Stock 20 | $ / shares | $ 0.001 |
Capital Stock 21 | $ | $ 0.001 |
Capital Stock 22 | 1 |
Capital Stock 23 | $ | $ 1 |
Capital Stock 24 | 500,000,000 |
Capital Stock 25 | $ | $ 0.001 |
Capital Stock 26 | 2,000,000,000 |
Capital Stock 27 | $ | $ 0.001 |
Capital Stock 28 | 2,000,000,000 |
Capital Stock 29 | 100,000,000 |
Capital Stock 30 | $ | $ 0.001 |
Capital Stock 31 | 50,000,000 |
Capital Stock 32 | 100,000,000 |
Capital Stock 33 | $ | $ 0.001 |
Capital Stock 34 | 62 |
Capital Stock 35 | yr | 1 |
Capital Stock 36 | 75.00% |
Capital Stock 37 | 2,000,000,000 |
Capital Stock 38 | $ | $ 0.001 |
Capital Stock 39 | 10,000,000,000 |
Capital Stock 40 | $ | $ 0.001 |
Capital Stock 41 | 125,000 |
Capital Stock 42 | $ / shares | $ 0.04 |
Capital Stock 43 | 201,465 |
Capital Stock 44 | $ / shares | $ 0.04 |
Capital Stock 45 | 250,000 |
Capital Stock 46 | $ / shares | $ 0.04 |
Capital Stock 47 | 100,000 |
Capital Stock 48 | $ / shares | $ 0.05 |
Capital Stock 49 | 298,269 |
Capital Stock 50 | $ / shares | $ 0.04 |
Capital Stock 51 | 250,000 |
Capital Stock 52 | $ / shares | $ 0.04 |
Capital Stock 53 | 80,801 |
Capital Stock 54 | $ / shares | $ 0.04 |
Capital Stock 55 | 434,084 |
Capital Stock 56 | $ / shares | $ 0.03 |
Capital Stock 57 | 438,000 |
Capital Stock 58 | $ / shares | $ 0.03 |
Capital Stock 59 | 486,623 |
Capital Stock 60 | $ / shares | $ 0.02 |
Capital Stock 61 | 475,000 |
Capital Stock 62 | $ / shares | $ 0.03 |
Capital Stock 63 | 394,231 |
Capital Stock 64 | $ / shares | $ 0.03 |
Capital Stock 65 | 8,044 |
Capital Stock 66 | $ / shares | $ 0.0001 |
Capital Stock 67 | 554,000 |
Capital Stock 68 | $ / shares | $ 0.01 |
Capital Stock 69 | 50,000,000 |
Capital Stock 70 | 100,000,000 |
Capital Stock 71 | $ | $ 0.001 |
Capital Stock 72 | 62 |
Capital Stock 73 | yr | 1 |
Capital Stock 74 | 75.00% |
Capital Stock 75 | 130,000 |
Capital Stock 76 | $ | $ 0.001 |
Capital Stock 77 | 0 |
Provision For Income Taxes (Nar
Provision For Income Taxes (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Provision For Income Taxes 1 | $ 13,213,863 |
Provision For Income Taxes 2 | 390,542 |
Provision For Income Taxes 3 | $ 1,130,089 |
Mineral Property Costs (Narrati
Mineral Property Costs (Narrative) (Details) - 6 months ended Dec. 31, 2015 | USD ($)d$ / sharesshares | CADdshares |
Mineral Property Costs 1 | 100.00% | 100.00% |
Mineral Property Costs 2 | $ 90,000 | |
Mineral Property Costs 3 | $ 90,000 | |
Mineral Property Costs 4 | CAD | CAD 40,000 | |
Mineral Property Costs 5 | CAD | 60,000 | |
Mineral Property Costs 6 | CAD | 100,000 | |
Mineral Property Costs 7 | CAD | 300,000 | |
Mineral Property Costs 8 | CAD | 50,000 | |
Mineral Property Costs 9 | CAD | 100,000 | |
Mineral Property Costs 10 | CAD | 20,000 | |
Mineral Property Costs 11 | CAD | CAD 80,000 | |
Mineral Property Costs 12 | 15.00% | 15.00% |
Mineral Property Costs 13 | 15.00% | 15.00% |
Mineral Property Costs 14 | CAD | CAD 80,000 | |
Mineral Property Costs 15 | 75.00% | 75.00% |
Mineral Property Costs 16 | CAD | CAD 100,000 | |
Mineral Property Costs 17 | $ 95,008 | |
Mineral Property Costs 18 | CAD | 20,000 | |
Mineral Property Costs 19 | 19,164 | |
Mineral Property Costs 20 | CAD | 80,000 | |
Mineral Property Costs 21 | 75,844 | |
Mineral Property Costs 22 | CAD | 106,667 | |
Mineral Property Costs 23 | 101,125 | |
Mineral Property Costs 24 | 26,667 | |
Mineral Property Costs 25 | CAD | 3,058 | |
Mineral Property Costs 26 | 2,899 | |
Mineral Property Costs 27 | CAD | 80,000 | |
Mineral Property Costs 28 | 75,844 | |
Mineral Property Costs 29 | CAD | 3,058 | |
Mineral Property Costs 30 | 2,899 | |
Mineral Property Costs 31 | CAD | CAD 83,058 | |
Mineral Property Costs 32 | $ 78,743 | |
Mineral Property Costs 33 | shares | 239 | 239 |
Mineral Property Costs 34 | $ / shares | $ 330 | |
Mineral Property Costs 35 | $ 25,000 | |
Mineral Property Costs 36 | $ 75,000 | |
Mineral Property Costs 37 | d | 180 | 180 |
Mineral Property Costs 38 | $ 700,000 | |
Mineral Property Costs 39 | d | 10 | 10 |
Mineral Property Costs 40 | shares | 500 | 500 |
Mineral Property Costs 41 | $ 1 | |
Mineral Property Costs 42 | shares | 500 | 500 |
Mineral Property Costs 43 | $ 4,940,000 | |
Mineral Property Costs 44 | shares | 500 | 500 |
Mineral Property Costs 45 | $ 2 | |
Mineral Property Costs 46 | 150,000 | |
Mineral Property Costs 47 | $ 15,000 | |
Mineral Property Costs 48 | shares | 10,000 | 10,000 |
Mineral Property Costs 49 | 25 | 25 |
Mineral Property Costs 50 | $ 20,000 | |
Mineral Property Costs 51 | $ 30,000 |
Convertible Promissory Notes (N
Convertible Promissory Notes (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Convertible Promissory Notes 1 | $ 36,000 |
Convertible Promissory Notes 2 | 10.00% |
Convertible Promissory Notes 3 | $ 52,720 |
Convertible Promissory Notes 4 | 33,231 |
Convertible Promissory Notes 5 | 19,489 |
Convertible Promissory Notes 6 | $ 30,000 |
Convertible Promissory Notes 7 | 10.00% |
Convertible Promissory Notes 8 | $ 54,495 |
Convertible Promissory Notes 9 | 30,000 |
Convertible Promissory Notes 10 | 24,495 |
Convertible Promissory Notes 11 | $ 27,000 |
Convertible Promissory Notes 12 | 10.00% |
Convertible Promissory Notes 13 | $ 306,808 |
Convertible Promissory Notes 14 | 27,000 |
Convertible Promissory Notes 15 | 279,808 |
Convertible Promissory Notes 16 | 12,000 |
Convertible Promissory Notes 17 | 115,109 |
Convertible Promissory Notes 18 | 12,000 |
Convertible Promissory Notes 19 | 103,109 |
Convertible Promissory Notes 20 | 18,000 |
Convertible Promissory Notes 21 | 72,119 |
Convertible Promissory Notes 22 | 18,000 |
Convertible Promissory Notes 23 | 54,119 |
Convertible Promissory Notes 24 | 18,000 |
Convertible Promissory Notes 25 | 72,119 |
Convertible Promissory Notes 26 | 18,000 |
Convertible Promissory Notes 27 | 54,119 |
Convertible Promissory Notes 28 | 17,000 |
Convertible Promissory Notes 29 | 27,706 |
Convertible Promissory Notes 30 | 17,000 |
Convertible Promissory Notes 31 | 10,706 |
Convertible Promissory Notes 32 | 149,379 |
Convertible Promissory Notes 33 | 320,322 |
Convertible Promissory Notes 34 | 875,252 |
Convertible Promissory Notes 35 | 1,584,896 |
Convertible Promissory Notes 36 | 1,015,698 |
Convertible Promissory Notes 37 | 1,646,448 |
Convertible Promissory Notes 38 | 1,070,492 |
Convertible Promissory Notes 39 | 180,505 |
Convertible Promissory Notes 40 | 8,660,230 |
Convertible Promissory Notes 41 | $ 423,387 |
Convertible Promissory Notes 42 | 4,087,472 |
Convertible Promissory Notes 43 | $ 116,043 |
Convertible Promissory Notes 44 | 261,331 |
Convertible Promissory Notes 45 | 749,582 |
Convertible Promissory Notes 46 | 143,375 |
Convertible Promissory Notes 47 | 606,206 |
Convertible Promissory Notes 48 | 3,098,801 |
Convertible Promissory Notes 49 | 245,829 |
Convertible Promissory Notes 50 | 118,255 |
Convertible Promissory Notes 51 | $ 0 |
Related Party Transactions (Nar
Related Party Transactions (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)shares | |
Related Party Transactions 1 | $ 1,115 |
Related Party Transactions 2 | 157,086 |
Related Party Transactions 3 | $ 58,990 |
Related Party Transactions 4 | shares | 2,167 |
Related Party Transactions 5 | $ 0 |
Related Party Transactions 6 | $ 47,537 |
Going Concern and Liquidity C32
Going Concern and Liquidity Considerations (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Going Concern And Liquidity Considerations 1 | $ 2,890,554 |
Going Concern And Liquidity Considerations 2 | 2,456,477 |
Going Concern And Liquidity Considerations 3 | 50,329,265 |
Going Concern And Liquidity Considerations 4 | $ 49,504,350 |
Commitments and Contingencies (
Commitments and Contingencies (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)mo$ / shares$ / moshares | |
Commitments And Contingencies 1 | mo | 24 |
Commitments And Contingencies 2 | $ 120,000 |
Commitments And Contingencies 3 | 12,000 |
Commitments And Contingencies 4 | $ 30,000 |
Commitments And Contingencies 5 | mo | 12 |
Commitments And Contingencies 6 | mo | 10 |
Commitments And Contingencies 7 | $ 12,000 |
Commitments And Contingencies 8 | $ / shares | $ 200 |
Commitments And Contingencies 9 | $ / mo | 10,000 |
Commitments And Contingencies 10 | shares | 500 |
Commitments And Contingencies 11 | $ 68,000 |
Commitments And Contingencies 12 | $ 13,656 |
Loan Receivable (Narrative) (De
Loan Receivable (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Loan Receivable 1 | $ 20,000 |
Loan Receivable 2 | $ 333.34 |
Loan Receivable 3 | 10.00% |
Loan Receivable 4 | 5.00% |
Loan Receivable 5 | $ 20,000 |
Loan Receivable 6 | 20,000 |
Loan Receivable 7 | $ 0 |
Discontinued Operations (Narrat
Discontinued Operations (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015CAD | |
Discontinued Operations 1 | 51.00% |
Discontinued Operations 2 | CAD 10,000 |
Subsequent Events (Narrative) (
Subsequent Events (Narrative) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Subsequent Events 1 | 10.00% |
Subsequent Events 2 | $ 5,500 |
Subsequent Events 3 | $ 500 |
Subsequent Events 4 | 10.00% |
Subsequent Events 5 | $ 24,750 |
Subsequent Events 6 | 2,250 |
Subsequent Events 7 | $ 2,500 |
Subsequent Events 8 | 10.00% |
Subsequent Events 9 | $ 13,200 |
Subsequent Events 10 | 1,200 |
Subsequent Events 11 | $ 2,000 |
Schedule of Deferred Tax Assets
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) | 6 Months Ended | |
Dec. 31, 2015 | Dec. 31, 2014 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1 | (35.00%) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2 | $ 784,846 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3 | 274,696 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4 | (545,832) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5 | (191,041) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6 | 464,286 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7 | 162,500 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8 | (320,322) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9 | (112,113) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10 | (7,565) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11 | (2,648) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12 | 390,542 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13 | 136,690 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14 | (390,542) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15 | (136,690) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16 | 0 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17 | $ 0 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1 | 35.00% | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2 | $ 297,085 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3 | 103,980 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4 | (118,990) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5 | (41,647) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6 | (99,567) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7 | (34,849) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8 | (1,584,896) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9 | (554,714) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10 | (898,887) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11 | (314,610) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12 | 2,918,297 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13 | 1,021,404 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14 | 513,042 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15 | 179,565 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16 | (513,042) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17 | (179,565) | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18 | 0 | |
Provision For Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19 | $ 0 |
Schedule of Summary of Converti
Schedule of Summary of Convertible Promissory Note (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 1 | $ 67,913 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 2 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 3 | (18,680) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 4 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 5 | 49,233 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 6 | 29,394 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 7 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 8 | (22,755) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 9 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 10 | 6,639 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 11 | 540,498 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 12 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 13 | (46,408) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 14 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 15 | 494,090 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 16 | 37,243 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 17 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 18 | (5,200) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 19 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 20 | 32,043 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 21 | 75,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 22 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 23 | (20,000) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 24 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 25 | 55,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 26 | 100,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 27 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 28 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 29 | 100,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 30 | 29,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 31 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 32 | (3,000) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 33 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 34 | 26,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 35 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 36 | 36,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 37 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 38 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 39 | 36,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 40 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 41 | 30,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 42 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 43 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 44 | 30,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 45 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 46 | 27,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 47 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 48 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 49 | 27,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 50 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 51 | 12,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 52 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 53 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 54 | 12,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 55 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 56 | 18,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 57 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 58 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 59 | 18,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 60 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 61 | 18,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 62 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 63 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 64 | 18,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 65 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 66 | 17,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 67 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 68 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 69 | 17,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 70 | 879,048 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 71 | 158,000 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 72 | (116,043) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 73 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 74 | 921,005 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 75 | (345,054) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 76 | (179,963) |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 77 | 533,994 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 78 | 741,042 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 79 | 533,994 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 80 | 741,042 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 81 | 0 |
Convertible Promissory Notes Schedule Of Summary Of Convertible Promissory Note 82 | $ 0 |
Schedule of Share-based Payment
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On August 03, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 2 | 269.35% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On August 03, 2015 3 | 0.17% |
Schedule of Share-based Payme40
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 09, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 2 | 275.84% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 09, 2015 3 | 0.39% |
Schedule of Share-based Payme41
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On September 30, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 2 | 375.79% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On September 30, 2015 3 | 0.33% |
Schedule of Share-based Payme42
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On November 6, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On November 6, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On November 6, 2015 2 | 383.46% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On November 6, 2015 3 | 0.47% |
Schedule of Share-based Payme43
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On December 1, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 2 | 392.28% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 3 | 0.51% |
Schedule of Stock Options, Valu
Schedule of Stock Options, Valuation Assumptions AS On December 1, 2015 With Aggregate $18,000 Convertible Promissory Notes (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 With An Aggregate $18,000 Convertible Promissory Notes Issuance 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 With An Aggregate $18,000 Convertible Promissory Notes Issuance 2 | 392.28% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 1, 2015 With An Aggregate $18,000 Convertible Promissory Notes Issuance 3 | 0.51% |
Schedule of Share-based Payme45
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions AS On December 3, 2015 (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 3, 2015 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 3, 2015 2 | 394.55% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions As On December 3, 2015 3 | 0.57% |
Schedule of Share-based Payme46
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 | 0.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 | 314.39 |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 | 459.51% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 | 258.89% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 | 49.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 | 1.06% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 | 11.00% |
Convertible Promissory Notes Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9 | 64.00% |
Schedule of Changes in Fair Val
Schedule of Changes in Fair Value of Convertible Promissory Notes (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 1 | $ 3,066,171 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 2 | 1,227,384 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 3 | (3,174,990) |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 4 | 527,883 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 5 | 1,646,448 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 6 | 701,073 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 7 | (261,331) |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 8 | (1,070,492) |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 9 | 1,015,698 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Convertible Promissory Notes 10 | $ 1,070,492 |
Schedule of Stockholders' Equit
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions (Details) | 6 Months Ended |
Dec. 31, 2015 | |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 1 | 0.00% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 2 | 0.00% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 3 | 248.00% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 4 | 288.96% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 5 | 1.31% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 6 | 1.76% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 7 | 1.01% |
Convertible Promissory Notes Schedule Of Stockholders' Equity Note, Warrants Or Rights, Valuation Assumptions 8 | 1.63% |
Schedule of Stockholders' Equ49
Schedule of Stockholders' Equity Warrants Activity (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)yr | |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 1 | $ 15,204 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 2 | 242.57 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 3 | yr | 2.62 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 4 | $ 19,104 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 5 | 236.92 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 6 | yr | 4.46 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 7 | $ (5,927) |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 8 | 257.08 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 9 | $ 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 10 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 11 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 12 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 13 | $ (1,289) |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 14 | 240 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 15 | $ 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 16 | $ 27,092 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 17 | 100.98 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 18 | yr | 3.79 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 19 | $ 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 20 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 21 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 22 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 23 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 24 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 25 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 26 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 27 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 28 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 29 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 30 | 0 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 31 | $ 27,092 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 32 | 100.98 |
Convertible Promissory Notes Schedule Of Stockholders' Equity Warrants Activity 33 | yr | 3.29 |
Schedule of Changes in Fair V50
Schedule of Changes in Fair Value of Financial Liabilities (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 1 | $ 5,416,000 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 2 | 791,407 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 3 | (2,730,022) |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 4 | (3,334,009) |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 5 | 143,376 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 6 | 0 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 7 | 0 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 8 | 606,206 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 9 | 749,582 |
Convertible Promissory Notes Schedule Of Changes In Fair Value Of Financial Liabilities 10 | $ 749,582 |
Schedule of Discontinued Operat
Schedule of Discontinued Operations, Consolidated Statements of Operations and Comprehensive Loss (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 1 | $ 0 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 2 | 41,300 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 3 | (78,570) |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 4 | (323,187) |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 5 | (78,570) |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Statements Of Operations And Comprehensive Loss 6 | $ (281,887) |
Schedule of Discontinued Oper52
Schedule of Discontinued Operations, Consolidated Balance Sheets (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 1 | $ 1,189 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 2 | 46,731 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 3 | 7,016 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 4 | 28,160 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 5 | 0 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 6 | 0 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 7 | 14,931 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 8 | 0 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 9 | 0 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 10 | (60,178) |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 11 | 23,136 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 12 | 14,713 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 13 | 6,034 |
Discontinued Operations Schedule Of Discontinued Operations, Consolidated Balance Sheets 14 | $ 6,696 |
Schedule of Effect on Condensed
Schedule of Effect on Condensed Consolidated Balance Sheet (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)shares | |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 1 | $ 64,099 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 2 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 3 | 64,099 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 4 | 13,421 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 5 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 6 | 13,421 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 7 | 20,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 8 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 9 | 20,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 10 | 2,788 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 11 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 12 | 2,788 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 13 | 14,713 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 14 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 15 | 14,713 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 16 | 115,021 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 17 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 18 | 115,021 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 19 | 115,021 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 20 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 21 | 115,021 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 22 | 65,962 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 23 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 24 | 65,962 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 25 | 3,134 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 26 | 140,241 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 27 | 143,375 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 28 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 29 | 1,646,448 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 30 | 1,646,448 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 31 | 115,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 32 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 33 | 115,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 34 | 300,887 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 35 | 233,107 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 36 | 533,994 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 37 | 60,022 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 38 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 39 | 60,022 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 40 | 6,696 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 41 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 42 | 6,696 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 43 | 551,701 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 44 | 2,019,796 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 45 | $ 2,571,497 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 46 | shares | 100,000,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 47 | $ 0.001 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 48 | shares | 10,000,000,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 49 | $ 0.001 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 50 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 51 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 52 | $ 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 53 | shares | 7,574,353 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 54 | $ 7,575 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 55 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 56 | 7,575 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 57 | 43,165,743 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 58 | 4,217,489 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 59 | 47,383,232 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 60 | (29,484) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 61 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 62 | (29,484) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 63 | (43,267,064) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 64 | (6,237,285) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 65 | (49,504,349) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 66 | (123,230) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 67 | (2,019,796) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 68 | (2,143,026) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 69 | (313,450) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 70 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 71 | (313,450) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 72 | (436,680) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 73 | (2,019,796) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 74 | (2,456,476) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 75 | 115,021 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 76 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Balance Sheet 77 | $ 115,021 |
Schedule of Effect on Condens54
Schedule of Effect on Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 1 | $ 41,300 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 2 | (41,300) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 3 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 4 | 15,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 5 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 6 | 15,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 7 | 908,916 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 8 | (323,188) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 9 | 585,728 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 10 | 923,916 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 11 | (323,188) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 12 | 600,728 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 13 | (882,616) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 14 | (281,888) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 15 | (600,728) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 16 | (2,671,540) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 17 | 1,635,637 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 18 | (1,035,903) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 19 | 2,818,577 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 20 | 99,720 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 21 | 2,918,297 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 22 | (97,070) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 23 | (97,070) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 24 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 25 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 26 | (1,584,896) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 27 | (1,584,896) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 28 | 6,145 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 29 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 30 | 6,145 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 31 | (826,504) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 32 | 529,419 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 33 | (297,085) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 34 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 35 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 36 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 37 | (826,504) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 38 | 529,419 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 39 | (297,085) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 40 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 41 | (281,887) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 42 | (281,887) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 43 | (826,504) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 44 | 247,532 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 45 | (578,972) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 46 | (138,125) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 47 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 48 | (138,125) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 49 | (688,379) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 50 | 247,532 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 51 | $ (440,847) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 52 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 53 | (3.22) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 54 | (3.22) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 55 | $ 547,109,178 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 56 | (546,972,401) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 57 | 136,777 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 58 | (826,504) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 59 | 247,532 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 60 | (578,972) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 61 | (7,834) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 62 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 63 | (7,834) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 64 | (834,338) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 65 | 247,532 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 66 | (586,806) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 67 | (138,125) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 68 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 69 | (138,125) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 70 | (696,213) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 71 | 247,532 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statement Of Operations And Comprehensive Income (loss) 72 | $ (448,681) |
Schedule of Effect on Condens55
Schedule of Effect on Condensed Consolidated Statements of Cash Flows (Details) | 6 Months Ended |
Dec. 31, 2015USD ($) | |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 1 | $ (826,504) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 2 | 529,419 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 3 | (297,085) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 4 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 5 | (281,887) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 6 | (281,887) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 7 | (6,145) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 8 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 9 | (6,145) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 10 | 118,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 11 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 12 | 118,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 13 | 2,544,024 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 14 | (1,635,637) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 15 | 908,387 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 16 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 17 | 1,584,896 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 18 | 1,584,896 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 19 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 20 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 21 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 22 | 99,567 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 23 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 24 | 99,567 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 25 | (2,818,577) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 26 | 99,720 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 27 | (2,918,297) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 28 | 97,070 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 29 | (97,070) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 30 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 31 | (1,749) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 32 | 1,749 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 33 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 34 | 19,074 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 35 | (2,464) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 36 | 16,610 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 37 | 27,949 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 38 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 39 | 27,949 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 40 | 62,497 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 41 | (28,812) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 42 | 33,685 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 43 | (683,804) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 44 | (29,527) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 45 | (713,331) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 46 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 47 | 15,779 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 48 | 15,779 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 49 | (683,804) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 50 | (13,748) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 51 | (697,552) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 52 | (45,332) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 53 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 54 | (45,332) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 55 | 750,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 56 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 57 | 750,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 58 | 704,668 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 59 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 60 | 704,668 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 61 | (7,834) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 62 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 63 | (7,834) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 64 | 13,030 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 65 | (13,746) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 66 | (718) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 67 | 69,732 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 68 | (12,100) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 69 | 57,632 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 70 | 82,762 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 71 | (25,846) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 72 | 59,914 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 73 | 2,205 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 74 | (2,205) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 75 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 76 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 77 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 78 | 2,493,048 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 79 | (1,018,846) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 80 | 1,474,202 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 81 | 408,962 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 82 | (408,962) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 83 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 84 | 766,675 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 85 | 1,605,259 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 86 | 2,371,934 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 87 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 88 | 2,286,445 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 89 | 2,286,445 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 90 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 91 | 743,481 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 92 | 743,481 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 93 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 94 | 1,642,368 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Cash Flows 95 | $ 1,642,368 |
Schedule of Effect on Condens56
Schedule of Effect on Condensed Consolidated Statements of Changes in Stockholders Deficit (Details) | 6 Months Ended |
Dec. 31, 2015USD ($)shares | |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 1 | $ 38,573,856 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 2 | 538,043 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 3 | 39,111,899 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 4 | 3,636,984 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 5 | (1,457,586) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 6 | 2,179,398 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 7 | 767,879 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 8 | 1,962,041 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 9 | 2,729,920 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 10 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 11 | 3,174,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 12 | 3,174,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 13 | 43,165,743 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 14 | 4,217,488 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 15 | 47,383,231 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 16 | (40,821,871) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 17 | (6,166,108) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 18 | (46,987,979) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 19 | (2,445,193) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 20 | (71,176) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 21 | (2,516,369) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 22 | (43,267,064) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 23 | (6,237,283) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 24 | (49,504,347) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 25 | (2,355,136) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 26 | $ (5,628,065) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 27 | shares | (7,983,201) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 28 | $ 118,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 29 | 118,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 30 | 68,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 31 | 68,000 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 32 | 767,981 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 33 | 1,962,039 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 34 | 2,730,020 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 35 | 3,644,405 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 36 | (1,457,585) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 37 | 2,186,820 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 38 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 39 | 3,174,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 40 | 3,174,990 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 41 | 38 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 42 | 0 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 43 | 38 |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 44 | (23,715) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 45 | (23,715) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 46 | (2,657,243) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 47 | (71,176) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 48 | (2,728,419) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 49 | (436,680) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 50 | (2,019,797) |
Restatement To Previously Issued Financial Statements Schedule Of Effect On Condensed Consolidated Statements Of Changes In Stockholders Deficit 51 | $ (2,456,477) |